VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Phase I study of recombinant human interleukin-3 in patients with bone marrow failure.
Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase I study of recombinant human interleukin-3 in patients with bone marrow failure.
Phase I study of recombinant human interleukin-3 in patients with bone marrow failure. J Clin Oncol. 1991 Jul; 9(7):1241-50.
View in:
PubMed
subject areas
Adult
Aged
Bone Marrow Diseases
Drug Administration Schedule
Drug Evaluation
Female
Humans
Interleukin-3
Male
Middle Aged
Pancytopenia
Recombinant Proteins
authors with profiles
ZEEV ESTROV